InterCure and Clever Leaves Announce International Strategic Partnership

Leading Global Cannabis Companies InterCure and Clever Leaves partner together to cultivate, market and distribute Pharmaceutical-Grade Medical Cannabis in the EU, Australia and Israel

Leading Global Cannabis Companies InterCure and Clever Leaves partner together to cultivate, market and distribute Pharmaceutical-Grade Medical Cannabis in the EU, Australia and Israel
Clever Leaves Logo

Clever Leaves Appoints William Muecke to Board of Directors

BOCA RATON, Fla., March 17, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced that it has appointed William Muecke to its board of directors, effective March 25, 2022, to fill the vacancy resulting from the previously announced departure of Kyle Detwiler, the Company’s current chairman and CEO, effective March 24, 2022. Muecke was also appointed to the board’s nominating and governance committee, as well as its compensation committee.

Clever leaves background

Clever Leaves to Hold Fourth Quarter and Full Year 2021 Conference Call on March 24, 2022 at 5:00 p.m. ET

BOCA RATON, Fla., March 10, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, March 24, 2022 at 5:00 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2021. The Company will provide its financial results in a press release prior to the conference call.

Clever Leaves to Present at the 34th Annual ROTH Conference

BOCA RATON, Fla., March 08, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the 34th Annual ROTH Conference, which is being held on March 13-15, 2022 at the Ritz Carlton in Dana Point, CA.